News | April 30, 2026
RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
The formulation is backed by over 80 clinical trials and 200 scientific publications
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Subscribe To Our Newsletter & Stay Updated
